Data gathered and calculated by Learnbonds.com indicates that stocks for leading cannabis companies have been on a steady decline over the last year. On average, the stock value for the five big players has declined by 67%.
Aurora Cannabis has taken the biggest hit after losing its stock value by 78,73% since February 2019. Tilray has also suffered a significant loss of 77.65% within a year. Cronos Group is the third most hit entity with a loss of about 68.54%.
Elsewhere, Aphria has also been affected by the industry hemorrhaging taking a loss of 59.54% followed by Canopy Growth with a 53.71% drop.
The current decline in hemp stocks might not end soon considering that the data indicates a high average monthly volatility rate. Aurora Cannabis has the highest volatility rate at 16% followed by Tilray’s rate of 15.18%.
Cronos Group is third with a volatility rate of 11.11% while Canopy Group has a volatility rate now 11%. Aphria has a volatility rate of 10.88%.
The decline in cannabis sticks can be attributed to various factors including lack of a clear legal framework.
According to the report, “This uncertainty has made it harder for marijuana companies to know how to operate within the law, which could expose them to legal risks.”
Although CBD is now being used to cure conditions such as epilepsy, lung illness-related illness as a result of vaping has been a major concern.
The legalization of cannabis in the US might be also in sight after the House Judiciary Committee approved the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act which is the first move towards Marijuana decriminalization in the US.
>>> London Loves Business readers receive a special 30% discount on this inspiring two day workshop to help grow your business more effectively in 2020